Patient
SITE007-0085
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2025-12-03
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-11-11 (study day 149); relationship: RELATED
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-10 (study day 148); relationship: RELATED
Grade 2 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-10-23 (study day 130); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-28 (study day 105); relationship: NOT RELATED
Grade 3 Dyspnoea — outcome: UNKNOWN; onset 2022-09-18 (study day 95); relationship: NOT RELATED
Grade 3 Alanine aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2022-07-13 (study day 28); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.